• Corpus ID: 1590997

Correlation analysis of the clinicopathological features of glioma and expression of p 53 and VEGF

  title={Correlation analysis of the clinicopathological features of glioma and expression of p 53 and VEGF},
  author={Jian-Guo Yang and Zhaohui Zhao and Xing-Ming Zhong},
Glioma is a common type of brain and neurological cancer with high degree of malignancy. Expression of p53 has been found in a variety of tumor cells and VEGF has been associated with the angiogenesis in cancers. In this study, the expressions of p53 and VEGF in glioma were examined. The relationship between clinicopathological features of glioma and the expression profiles of p53 and VEGF was analyzed. Levels of p53 and VEGF in the serum of glioma patients were detected by ELISA… 
3 Citations

Figures and Tables from this paper

VEGF-A, VEGFR-2 and MVD in brain tumor tissue

Neoangiogenesis plays a crucial role in tumor development. The method that is most commonly recommended for assessing this process is determining the so-called microvessel density (MVD) in the tissue

Serum VEGF-A concentrations in patients with central nervous system (CNS) tumors

The highest average preoperative serum VEGF-A level was found in patients with low grade gliomas, slightly lower (close to each other) in those with high gradegliomas and meningioma, while the lowest level was characteristic for metastatic tumors.

Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review

Which molecules, including proteins, nucleic acids, circulating cells, and metabolomics, are most promising blood-based biomarkers for glioma diagnosis, prognosis, monitoring and other purposes, and align them to the seminal processes of cancer are questioned.



The potential of ki67 and p53 assessment in development of individualized targeted therapy in breast cancer patients.

This study confirms the expression of p53 and Ki67 as strong individual indicators of patient outcome, however, when controlling for the other variables, the two markers are not independent predictors.

Immunoexpression of HIF-1α and VEGF in Periodontal Disease and Healthy Gingival Tissues.

The increased expression of Hif-1α and VEGF in periodontitis, compared to gingivitis and healthy gingiva, suggests possible activation of the HIF-1 α pathway in advanced periodontal disease.

Evaluation of Preoperative Serum Levels of CA 125 and Expression of p53 in Ovarian Neoplasms: A Prospective Clinicopathological Study in a Tertiary Care Hospital

Higher values of preoperative CA 125 levels and higher expression p53 are associated with MSESTs and BOTs especially of serous type, but there is no serum CA 125 concentration that can clearly differentiate benign and malignant ovarian masses.

p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.

Assessment of p53, cyclin D1, p21 (WAF1), and Ki-67 (MIB1) at the ITF could help to predict local recurrence in early stage oral squamous cell carcinoma cases.

Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients.

Results indicate that serum OPG level may be used as a diagnostic tool and a prognostic variable for patients with muscle invasive bladder cancer, and future trials are required to elucidate its therapeutic role in such patients.

Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1

Results show that Nano HAP-shRNA-SATB1 can inhibit the growth of human glioma U251 cells in vitro and in vivo, and hydroxyapatite nanoparticles can be used for the in vitroand in vivo delivery of plasmid-based shRNAs into U 251 cells.

Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis

The findings indicate that the dsP53-285 can upregulate wild-type p53 expression in human bladder cancer cells through RNA activation, and suppresses cells proliferation and metastasis in vitro and in vivo.

Multistep Model of Cervical Cancer: Participation of miRNAs and Coding Genes

The present model is a useful insight into studying potential prognostic, diagnostic, and therapeutic miRNAs for cervical cancer research through a multistep model of carcinogenesis.

Synergistic Antivascular and Antitumor Efficacy with Combined Cediranib and SC6889 in Intracranial Mouse Glioma

The study represents the first demonstration that the combination of cediranib with a proteasome inhibitor substantially increases the anti-angiogenic efficacy produced from either agent alone, and synergistically slows glioma tumor growth and extends survival, suggesting a promising treatment which warrants further investigation.